Page updated: 19 September 2017

Articles

 

Effect of allergic bronchopulmonary aspergillosis on FEV1 in children and adolescents with cystic fibrosis: a European Cystic Fibrosis Society Patient Registry analysis. 
Kaditis AG, Miligkos M, Bossi A, Colombo C, Hatziagorou E, Kashirskaya N, Monestrol de I, Thomas M, Mei-Zahav M, Chrousos G, Zolin A.
Archives of Disease in Childhood Aug 2017, 102 (8) 742-747; DOI: 10.1136/archdischild-2016-311132. Link to Article
Year to year change in FEV1 in patients with cystic fibrosis and different mutation classes.
De Boeck K., Zolin A.
J Cyst Fibros. 2016 Oct 11. pii: S1569-1993(16)30611-7. doi: 10.1016/j.jcf.2016.09.009. [Epub ahead of print].  Link to Article
Future trends in Cystic Fibrosis demography in 34 European countries. 
Burgel P-R;  Bellis G, Olesen HV, Viviani L, Zolin A, Blasi F and Elborn JS. on behalf of the ERS/ECFS Task Force on The Provision of Care for Adults with Cystic Fibrosis in Europe 2015. 
European Respiratory Journal 2015 Mar 18. pii: ERJ-01963-2014. Link to Article
The relative frequency of CFTR mutation classes in European patients with cystic fibrosis. 
De Boeck K, Zolin A, Cuppens H, Olesen HV, Viviani L. 
Journal of Cystic Fibrosis 2014, Jul;13(4):403-9. Link to Article
Multi-Country Estimate of Different Manifestations of Aspergillosis in Cystic Fibrosis.
Amstead J., Morris J., Denning D.W.
PlosOne 2014, June 10. Link to Article
The European Cystic Fibrosis Society Patient Registry: valuable lessons learned on how to sustain a disease registry.
Laura Viviani, Anna Zolin, Anil Mehta, Hanne Vebert Olesen.
Orphanet Journal of Rare Diseases 2014, 9:81, doi:10.1186/1750-1172-9-81.  Link to Article
Factors associated with FEV1 decline in cystic fibrosis: analysis of the data of the ECFS Patient Registry.
Kerem E, Viviani L, Zolin A, Macneill S, Hatziagorou E, Ellemunter H, Drevinek P, Gulmans V, Krivec U, Olesen H; on behalf of the ECFS Patient Registry Steering Group.
The European Respiratory Journal 2014 Jan;43(1):125-33. Link to Article
Evidence of diminished FEV1 and FVC in 6-year-olds followed in the European cystic fibrosis patient registry, 2007-2009.
Vandevanter DR, Pasta DJ. 
Journal of Cystic Fibrosis 2013 (12): 786-789. Link to Article
A new era in the treatment of cystic fibrosis: correction of the underlying CFTR defect. 
Boyle MP, De Boeck K.
The Lancet Respiratory Medicine 2013(1): 158-163. Link to Article
Epidemiology of Cystic Fibrosis Lung Disease progression in adolescents in ECFS Book on Healthcare Issues and challenges in Adolescents in CF, December 2012. 
Dutch VanDevanter. Link to Article
Reference percentiles for FEV(1) and BMI in European children and adults with cystic fibrosis.
Boëlle PY, Viviani L, Busson PF, Olesen HV, Ravilly S, Stern M, Assael BM, Barreto C, Drevinek P, Thomas M, Krivec U, Mei-Zahav M, Vibert JF, Clement A, Mehta A, Corvol H on behalf of the French CF Modifier Gene Study Investigators and the European CF Registry Working Group.
Orphanet Journal of Rare Diseases 2012 (1): 64. Link to Article
Cystic fibrosis across Europe: EuroCareCF analysis of demographic data from 35 countries. 
Mehta G, Macek M Jr, Mehta A on behalf of the European registry Working Group.
Journal of Cystic Fibrosis 2010  (9 Suppl 2): S5-S21.  Link to Article
Comparative demographics of the European cystic fibrosis population: a cross-sectional database analysis.
McCormick J, Mehta G, Olesen HV, Viviani L, Macek M, Mehta A.
The Lancet 2010 (375): 1007-1013.  Link to Article